User profiles for Duygu Has Simsek

duygu has simsek

Istanbul University
Verified email at istanbul.edu.tr
Cited by 610

Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic …

DH Simsek, S Kuyumcu, C Turkmen… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Gastroenteropancreatic neuroendocrine tumors (GEPNETs) are indolent neoplasms
presenting unpredictable and unusual biologic behavior that causes many clinical challenges. …

[HTML][HTML] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer

Y Sanli, DH Simsek, O Sanli, RM Subramaniam… - Biomedicines, 2021 - mdpi.com
The aim of this narrative review is to evaluate the current status of 177 Lu-PSMA (prostate
specific membrane antigen) therapy for metastatic castration-resistant prostate cancer (…

Evidence of prostate-specific membrane antigen expression in hepatocellular carcinoma using 68Ga-PSMA PET/CT

S Kuyumcu, D Has-Simsek, R Iliaz, Y Sanli… - Clinical nuclear …, 2019 - journals.lww.com
Materials and Methods Nineteen HCC patients who underwent 18 F-fluorodeoxyglucose (18
F-FDG) positron emission tomography (PET) as part of restaging procedure also underwent …

Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?

D Has Simsek, S Kuyumcu, S Karadogan… - Annals of Nuclear …, 2021 - Springer
Purpose We investigated the role of PSMA-derived tumor burden in predicting docetaxel (DTX)
therapy response in metastatic castration-resistant prostate cancer (mCRPC). Methods …

Detection of metastases in newly diagnosed prostate cancer by using 68Ga-PSMA PET/CT and its relationship with modified D'Amico risk classification

DH Simsek, Y Sanli, MN Engin, S Erdem… - European journal of …, 2021 - Springer
Purpose We aimed to investigate the diagnostic power of 68Ga-PSMA PET/CT in the detection
of metastatic spread of newly diagnosed PCa, and evaluate the relationship with modified …

Safety of fibroblast activation protein–targeted radionuclide therapy by a low-dose dosimetric approach using 177Lu-FAPI04

…, Y Sanli, F Buyukkaya, DH Simsek… - Clinical nuclear …, 2021 - journals.lww.com
… The role of nonneoplastic cells within the tumor microenvironment (TME) has
increasingly been a focus of interest due to their role in tumor progression and therapeutic …

Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?

DH Simsek, Y Sanli, C Civan, MN Engin, EG Isik… - Annals of Nuclear …, 2020 - Springer
Objection We aimed to evaluate the role of bone scintigraphy (BS) which has long been the
imaging modality of choice in prostate cancer (PCa) and performed a head-to-head …

Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results

S Kuyumcu, EG Isik, TO Tiryaki, D Has-Simsek… - Annals of nuclear …, 2021 - Springer
Purpose This study investigates the prognostic value of 68 Ga-Pentixafor PET/CT using PET-derived
quantitative in multiple myeloma (MM) patients with suspected recurrence in …

Fibroblast activation protein–targeted PET imaging of metastatic castration-resistant prostate cancer compared with 68Ga-PSMA and 18F-FDG PET/CT

EG Isik, D Has-Simsek, O Sanli, Y Sanli… - Clinical nuclear …, 2022 - journals.lww.com
Herein we present 2 mCRPC (metastatic castration-resistant prostate cancer) patients who
underwent 68 Ga-PSMA PET/CT for PSMA-targeted radioligand therapy eligibility. Prior …

The role of [68 Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study

C Civan, S Kuyumcu, D Has Simsek, O Sanli… - European Journal of …, 2024 - Springer
Purpose We aimed to investigate the role of [ 68 Ga]Ga-FAPI-04 PET/CT and uptake patterns
of primary and metastatic lesions in patients with renal cell carcinoma (RCC). Methods …